Feds Deciding When Healthcare Science Costs Too Much To Save Lives

By: cringinghere (Diary)  |  October 22nd at 11:01 AM  | 

If anyone wants a current example of what is looming ahead for medical science at the hands of Obamacare, the Avastin controversy is a perfect one. The Food and Drug Administration (FDA) wants to de-list the cancer drug Avastin one reason being that it is a drug too expensive for government to fund. It is scary to think that the federal government can summarily dismiss | Read More »